This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Guerrero, S. Articles by Mangues, R. Search for Related Content PubMed PubMed Citation Articles by Guerrero, S. Articles by Mangues, R.

K-ras Codon 12 Mutation Induces Higher Level of Resistance to Apoptosis and Predisposition to Anchorage-independent Growth Than Codon 13 Mutation or Proto-Oncogene Overexpression¹

Laboratori d’Investigació Gastrointestinal, Institut de Recerca, Hospital de Sant Pau, 08025 Barcelona [S. G., I. C., L. F., R. M.]; Departament de Bioquímica i Biologia Molecular, Facultat de Químiques, Universitat de Barcelona 08028 [A. M.]; and Laboratori de Recerca Traslacional, Institut Català d’Oncologia, 08907 Barcelona [G. C.], Spain

The position of the point mutation in the c-K-ras gene appears associated with different degrees of aggressiveness in human colorectal tumors. In addition, colon tumors carrying K-ras codon 12 mutations associate with lower levels of apoptosis than tumors lacking this mutation. To test the hypothesis of a distinct transforming capacity of different K-ras forms in an in vitro system, we generated stable transfectants of NIH3T3 cells expressing a plasmid containing K-ras mutated at codon 12 (K12) or at codon 13 (K13), or overexpressing the K-ras proto-oncogene (Kwt-oe). We evaluated changes in morphology, proliferative capacity, contact inhibition, and predisposition to apoptosis and anchorage-independent growth in K12, K13, and Kwt-oe transformants. In addition, we studied alterations in expression and/or activation of proteins that participate in signal transduction downstream of Ras or are involved in the regulation of apoptosis and cell-cell (E-cadherin and ß-catenin) and cell-substrate (focal adhesion kinase) interactions. We observed that K13 or Kwt-oe transformants died synchronically 24–48 h after reaching confluency. Their death was apoptotic. In contrast, K12 grew, forming bigger colonies with higher cell densities; and before reaching confluency, spontaneously formed spheroids and showed no sign of apoptosis. The enhanced resistance to apoptosis, loss of contact inhibition, and predisposition to anchorage-independent growth in the K12 transformants were associated with higher AKT/protein kinase B activation, bcl-2, E-cadherin, ß-catenin, and focal adhesion kinase overexpression, and RhoA underexpression, whereas the increased sensitivity of K13 or Kwt-oe transformants to apoptosis was associated with increased activation of the c-Jun-NH₂-terminal kinase 1 pathway. All transformants showed a similar overactivation of mitogen-activated protein kinases and levels of bax expression similar to the endogenous level. Therefore, in our in vitro model, the localization of the mutation in the K-ras gene predisposes to a different level of aggressiveness in the transforming phenotype. K12 may increase aggressiveness not by altering proliferative pathways, but by the differential regulation of K-Ras downstream pathways that lead to inhibition of apoptosis, enhanced loss of contact inhibition, and increased predisposition to anchorage-independent growth. These results offer a molecular explanation for the increased aggressiveness of the tumors with K-ras codon 12 mutations observed in the clinical setting.

This article has been cited by other articles:

				M. V. Cespedes, F. J. Sancho, S. Guerrero, M. Parreno, I. Casanova, M. A. Pavon, E. Marcuello, M. Trias, M. Cascante, G. Capella, et al. K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12 Carcinogenesis, November 1, 2006; 27(11): 2190 - 2200. [Abstract] [Full Text] [PDF]

				P. Vizan, L. G. Boros, A. Figueras, G. Capella, R. Mangues, S. Bassilian, S. Lim, W.-N. P. Lee, and M. Cascante K-ras Codon-Specific Mutations Produce Distinctive Metabolic Phenotypes in Human Fibroblasts Cancer Res., July 1, 2005; 65(13): 5512 - 5515. [Abstract] [Full Text] [PDF]

				V. D. Leaner, H. Donninger, C. A. Ellis, G. J. Clark, and M. J. Birrer p75-Ras-GRF1 Is a c-Jun/AP-1 Target Protein: Its Up Regulation Results in Increased Ras Activity and Is Necessary for c-Jun-Induced Nonadherent Growth of Rat1a Cells Mol. Cell. Biol., April 15, 2005; 25(8): 3324 - 3337. [Abstract] [Full Text] [PDF]

				C. Greco, R. Vona, M. Cosimelli, P. Matarrese, E. Straface, P. Scordati, D. Giannarelli, V. Casale, D. Assisi, M. Mottolese, et al. Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions Glycobiology, September 1, 2004; 14(9): 783 - 792. [Abstract] [Full Text] [PDF]

				P. M. Ghosh, R. Bedolla, M. Mikhailova, and J. I. Kreisberg RhoA-dependent Murine Prostate Cancer Cell Proliferation and Apoptosis: Role of Protein Kinase C{zeta} Cancer Res., May 1, 2002; 62(9): 2630 - 2636. [Abstract] [Full Text] [PDF]